Premium
Review article: Potential cellular therapies for renal disease: Can we translate results from animal studies to the human condition?
Author(s) -
LITTLE MELISSA H,
RAE FIONA K
Publication year - 2009
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/j.1440-1797.2009.01144.x
Subject(s) - medicine , renal stem cell , kidney disease , disease , stem cell , kidney , mesenchymal stem cell , bioinformatics , pathology , intensive care medicine , progenitor cell , biology , microbiology and biotechnology
SUMMARY The incidence of chronic kidney disease is increasing worldwide, prompting considerable research into potential regenerative therapies. These have included studies to determine whether an endogenous renal stem cell exists in the postnatal kidney and whether non‐renal adult stem cells, such as mesenchymal stem cell, can ameliorate renal damage. Such stem cells will either need to be recruited to the damaged kidney to repair the damage in situ or be differentiated into the desired cell type and delivered into the damaged kidney to subsequently elicit repair without maldifferentiation. To date, these studies have largely been performed using experimental and genetic models of renal damage in rodents. The translation of such research into a therapy applicable to human disease faces many challenges. In this review, we examine which animal models have been used to evaluate potential cellular therapies and how valid these are to human chronic kidney disease.